540 results on '"Quindós, Guillermo"'
Search Results
52. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis
53. Latest developments in fungal lung infection in solid organ transplantation (SOT)
54. Erratum for Miranda-Cadena et al., “Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti- Candida Activities”
55. Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models
56. Actividad in vitro de la anfotericina B y la anidulafungina sobre biopelículas de Candida albicans y Candida tropicalis
57. Actividad antifúngica in vitro de voriconazol: Nuevos datos después de los primeros años de experiencia clínica
58. Update on invasive fungal infections: the last two years
59. In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris
60. Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti- Candida Activities
61. Candida parapsilosis Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates
62. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis
63. Utilidad de la detección de (1→3)-ß-D-glucano y anticuerpos anti-micelio de Candida albicans para el diagnóstico y seguimiento terapéutico de la candidiasis invasora en pacientes neutropénicos adultos
64. Anticuerpos anti-micelio de Candida albicans en dos pacientes de cuidados intensivos con candidiasis invasora
65. Mecanismos de resistencia a la terapéutica antifúngica
66. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
67. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital
68. Phospholipase and proteinase activities of Candida isolates from denture wearers
69. Candida duobushaemulonii: An Old But Unreported Pathogen
70. Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis , and Candida bracarensis Virulence and Antifungal Efficacy
71. Synthesis, Physical, Mechanical and Antibacterial Properties of Nanocomposites Based on Poly(vinyl alcohol)/Graphene Oxide–Silver Nanoparticles
72. Utility of two PCR‐RFLP‐based techniques for identification of Candida parapsilosis complex blood isolates
73. Graphene Oxide–Silver Nanoparticle Nanohybrids: Synthesis, Characterization, and Antimicrobial Properties
74. Galleria mellonella insektua eta Caenorhabditis elegans nematodoa, infekzio eredu boteretsuak Candida glabrata eta erlazionatutako espezieen birulentzia ikertzeko
75. In vitro activity of voriconazole against Mexican oral yeast isolates
76. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity
77. Prevalencia, microbiología y patrones de sensibilidad a los antifúngicos de los aislamientos orales de Candida que colonizaban o infectaban a pacientes mexicanos con infección por VIH o sida y a personas sanas
78. Utility of albicans ID plate for rapid identification of Candida albicans in clinical samples: Rapid identification of Candida albicans
79. Candida biotypes in patients with oral leukoplakia and lichen planus: Candida bio types in leukoplakia and lichen planus
80. Sertaconazole: updated review of a topical antifungal agent
81. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections
82. Evaluación de una nueva técnica comercializada (Candida albicans IFA IgG) para el diagnóstico de la candidiasis invasiva
83. Fatal Candida famata Peritonitis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis Who Was Treated with Fluconazole
84. Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method
85. Disinfectant Activity of A Portable Ultraviolet C Equipment
86. Corrigendum: Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida
87. In vitro activities of natural products against oral Candida isolates from denture wearers
88. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
89. Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010
90. Declaración a favor de la creación de la Asociación Iberoamericana de Micología Médica
91. Virulence of Candida aurisfrom different clinical origins in Caenorhabditis elegansand Galleria mellonellahost models
92. Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida
93. Study of microbiological laboratory techniques for the etiological diagnosis and guidance in the treatment of invasive candidiasis
94. Editorial: EHUDW01, First EHU-DELFIN Program Workshop, Bilbao, Jul, 201
95. Erratum to: “EPICO 3.0. Management of non-neutropenic patients in medical wards” [Rev Iberoam Micol. 33 (4) (2016) 216–223]
96. La utilidad clínica de los derivados triazólicos en el tratamiento de las infecciones fúngicas
97. Micosis sistémicas endémicas o primarias
98. Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses.
99. Chapter 17 - State of the Art in the Laboratory Methods for the Diagnosis of Invasive Fungal Diseases
100. Twitter as a Tool for Teaching and Communicating Microbiology: The #microMOOCSEM Initiative
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.